Fulgent Genetics, Inc.
—Price / book
Market cap
—
Tangible equity
$953.63M
Price / tangible book
—
Price / book
—
Return on equity
-5.4%
Return on assets
-5.0%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FLGT stock price vs PFG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PFG's multiple
Needs PFG P/B.
Implied fair value · at FLGT's multiple
Needs FLGT P/B.
Metric by metric
Price unavailable
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: FLGT FY 2025 (ended Dec 31, 2025) · PFG FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity
$953.63M
Price / tangible book
—
Price / book
—
Return on equity
-5.4%
Return on assets
-5.0%
Efficiency ratio
—
Price / book
Market cap
—
Tangible equity
$9.02B
Price / tangible book
—
Price / book
—
Return on equity
10.0%
Return on assets
0.3%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FULGENT GENETICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
PRINCIPAL FINANCIAL GROUP, INC · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.00x
0.33x
Net debt / EBITDA
Leverage against operating earnings
1.15x
-0.30x
Cash and equivalents
Liquid reserves on the balance sheet
$50.19M
$4.43B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
FLGT vs NEO
Natera, Inc.
FLGT vs NTRA
Guardant Health, Inc.
FLGT vs GH
EXACT SCIENCES CORP
FLGT vs EXAS
OPKO HEALTH, INC.
FLGT vs OPK
METLIFE INC
FLGT vs MET
PRUDENTIAL FINANCIAL INC
FLGT vs PRU
LINCOLN NATIONAL CORP
FLGT vs LNC
HARTFORD FINANCIAL SERVICES GROUP, INC.
FLGT vs HIG
AMERIPRISE FINANCIAL INC
FLGT vs AMP
$476.00K
$3.95B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.